Rothschild Investment LLC’s United Therapeutics UTHR Stock Holding History

Rothschild Investment LLC’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$190K	Buy	350 +3	+0.9%	+$1.69K	0.01%	874
2026 Q1	$206K	Sell	347 -257	-43%	-$128K	0.01%	661
2025 Q4	$294K	Buy	604 +418	+225%	+$195K	0.02%	499
2025 Q3	$78K	Buy	+186	New	+$62.6K	﹤0.01%	868
2025 Q2	–	Sell	-1	Closed	-$308	–	3195
2025 Q1	$308	Hold	1	–	–	﹤0.01%	2759
2024 Q4	$353	Hold	1	–	–	﹤0.01%	2657
2024 Q3	$358	Buy	+1	New	+$338	﹤0.01%	2564

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Rothschild Investment LLC's UTHR Position: Q2 2026 in Review

Rothschild Investment LLC increased its United Therapeutics (UTHR) stake by 0.86% in Q2 2026, buying an estimated $1.69K and bringing the position to 350 shares worth $190K. The position accounts for 0.01% of the portfolio, ranked #874.

Rothschild Investment LLC first reported a position in UTHR in Q3 2024 and has held it in 7 quarters since. The position peaked at $294K in Q4 2025. 417 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Rothschild Investment LLC held 350 shares of United Therapeutics worth $190K as of Q2 2026.
Rothschild Investment LLC bought 3 United Therapeutics shares in Q2 2026, an estimated $1.69K.
United Therapeutics made up 0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #874 holding.
Rothschild Investment LLC first reported a position in United Therapeutics in Q3 2024 and has held it in 7 quarters since.
Rothschild Investment LLC's United Therapeutics position peaked at $294K in Q4 2025.
417 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.